Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.83 USD | +0.34% | +4.69% | +36.61% |
19/04 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
01/04 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.61% | 2.42B | |
+14.09% | 3,161B | |
+11.00% | 87.62B | |
+6.51% | 79.59B | |
-12.92% | 54.14B | |
+23.70% | 48.15B | |
+32.92% | 47.69B | |
-25.15% | 46.81B | |
+80.89% | 42B | |
-5.92% | 25.77B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Earnings Flash (CLBT) CELLEBRITE DI Reports Q3 Revenue $84.2M, vs. Street Est of $82.1M